Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

InfuSystem Holdings (INFU) Cost of Revenue (2016 - 2025)

InfuSystem Holdings (INFU) has disclosed Cost of Revenue for 16 consecutive years, with $2.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cost of Revenue fell 94.11% year-over-year to $2.4 million, compared with a TTM value of $10.5 million through Dec 2025, down 83.73%, and an annual FY2025 reading of $10.5 million, down 83.73% over the prior year.
  • Cost of Revenue was $2.4 million for Q4 2025 at InfuSystem Holdings, up from $2.4 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $41.3 million in Q4 2024 and bottomed at -$35.0 million in Q4 2023.
  • Average Cost of Revenue over 5 years is $3.6 million, with a median of $3.0 million recorded in 2023.
  • The sharpest move saw Cost of Revenue plummeted 146.7% in 2023, then surged 470.52% in 2024.
  • Year by year, Cost of Revenue stood at -$20.2 million in 2021, then rose by 29.85% to -$14.2 million in 2022, then tumbled by 146.7% to -$35.0 million in 2023, then skyrocketed by 218.12% to $41.3 million in 2024, then plummeted by 94.11% to $2.4 million in 2025.
  • Business Quant data shows Cost of Revenue for INFU at $2.4 million in Q4 2025, $2.4 million in Q3 2025, and $2.7 million in Q2 2025.